Sfoglia per AUTORE
DE SIMONE I
Collezione AOU Alessandria

  

Items : 4

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.
2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study. in International journal of molecular sciences / Int J Mol Sci. 2022 May 21;23(10):5786. doi: 10.3390/ijms23105786.
2022
AOU Alessandria
ASL Alessandria

Ceresoli GL; Marchini S; Allavena P; Zucali PA; Muzio A; Delfanti S; De Angelis A; Libener R; Penpa S; Callari M; Inglesi A; Amodeo R; Lupi M; Bosetti C; Vedovelli L; De Simone I; Moracci L; Olteanu GE; Pezzuto F; Paracchini L; Mannarino L; Calabrese F; D'Incalci M; Grosso F;

2022
AOU Alessandria

Mannarino L; Mirimao F; Panini N; Paracchini L; Marchini S; Beltrame L; Amodeo R; Grosso F; Libener R; De Simone I; Ceresoli GL; Zucali PA; Lupi M; D'Incalci M;

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma. in ESMO open / ESMO Open. 2022 Dec;7(6):100644. doi: 10.1016/j.esmoop.2022.100644. Epub 2022 Dec 1.
2022
AOU Alessandria

Canova S; Ceresoli GL; Grosso F; Zucali PA; Gelsomino F; Pasello G; Mencoboni M; Rulli E; Galli F; De Simone I; Carlucci L; De Angelis A; Belletti M; Bonomi M; D'Aveni A; Perrino M; Bono F; Cortinovis DL;